These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28810116)

  • 21. Current state of knowledge on oral anticoagulant reversal using procoagulant factors.
    Nitzki-George D; Wozniak I; Caprini JA
    Ann Pharmacother; 2013 Jun; 47(6):841-55. PubMed ID: 23695644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversing anti-factor Xa agents and the unmet needs in trauma patients.
    Hunt BJ; Neal MD; Stensballe J
    Blood; 2018 Dec; 132(23):2441-2445. PubMed ID: 30309890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Direct oral anticoagulant associated bleeding].
    Godier A; Martin AC; Rosencher N; Susen S
    J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yan BP; Yu CM
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):23-35. PubMed ID: 23224686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anticoagulant activity is rapidly reversed].
    Darius H
    MMW Fortschr Med; 2016 Feb; 158(2):67. PubMed ID: 27017636
    [No Abstract]   [Full Text] [Related]  

  • 26. Bleeding risk assessment and management in atrial fibrillation patients.
    Lip GY
    Eur Heart J; 2012 Jan; 33(2):147-9. PubMed ID: 22246817
    [No Abstract]   [Full Text] [Related]  

  • 27. Universal, class-specific and drug-specific reversal agents for the new oral anticoagulants.
    Ansell JE
    J Thromb Thrombolysis; 2016 Feb; 41(2):248-52. PubMed ID: 26449414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An antidote to the direct oral anticoagulants].
    Wagner E
    Rev Med Suisse; 2016 Jan; 12(500):108. PubMed ID: 26946718
    [No Abstract]   [Full Text] [Related]  

  • 29. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [First NOAK antidote soon to be approved].
    Holzgreve H
    MMW Fortschr Med; 2015 Aug; 157(14):34. PubMed ID: 26289876
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of acute bleeding with recombinant factor VIIa in a patient with IgA deficit receiving anticoagulant therapy.
    Sanchis Cervera J; Andrés Blasco CJ; Mena-Duran AV
    Acta Haematol; 2003; 110(1):51-2. PubMed ID: 12975561
    [No Abstract]   [Full Text] [Related]  

  • 33. Emergency admissions for major haemorrhage associated with direct oral anticoagulants.
    Bouget J; Oger E
    Thromb Res; 2015 Dec; 136(6):1190-4. PubMed ID: 26545315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel oral anticoagulants in the treatment of cerebral venous thrombosis.
    Feher G; Illes Z; Komoly S; Hargroves D
    Int Angiol; 2016 Aug; 35(4):365-8. PubMed ID: 25994451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral anticoagulant therapy in patients with atrial fibrillation.
    Pengo V
    Semin Vasc Med; 2003 Aug; 3(3):333-8. PubMed ID: 15199467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
    Fernandez MM; von Schéele B; Hogue S; Kwong WJ
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Who, when, and how to reverse non-vitamin K oral anticoagulants.
    Aronis KN; Hylek EM
    J Thromb Thrombolysis; 2016 Feb; 41(2):253-72. PubMed ID: 26627486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergent Bleeding in Patients Receiving Direct Oral Anticoagulants.
    Summers RL; Sterling SA
    Air Med J; 2016; 35(3):148-55. PubMed ID: 27255877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current and future role of the novel oral anticoagulants--indications beyond atrial fibrillation.
    Lee A; Rajaratnam R
    Heart Lung Circ; 2014 Jan; 23(1):2-9. PubMed ID: 24183214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation.
    Sarma A; Giugliano RP
    Hosp Pract (1995); 2015; 43(5):258-67. PubMed ID: 26559852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.